Physician profile
Brandy Carr
NPI 1427418474
$2,803.46
in general payments reported to CMS, 2019-2025
17 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $701 · 2022: $831 · 2023: $459 · 2024: $376 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $561.52 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $477.50 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $460.85 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $207.41 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $206.21 | 2023-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $176.81 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $145.95 | 2021-2022 | |
| Pfizer INC. | $136.95 | 2022-2025 | |
| Boston Scientific Corporation | $80.76 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor |
| Silk Road Medical, INC. | $77.68 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.95 | 2022 | |
| Medtronic, INC. | $52.82 | 2022-2024 | Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.67 | 2025 | Lifevest |
| Inspire Medical Systems, INC. | $32.69 | 2025 | Inspire |
| Daiichi Sankyo INC. | $24.58 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.83 | 2022 | |
| Esperion Therapeutics, INC. | $15.28 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.